The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The plasminogen activator/plasmin system.
Open accessAbstract
proteases and inhibitors has been shown to be under the control of hormones and growth factors. Plasminogen activators (PAs) and their inhibitors (PAIs) are thought to be key participants in the balance ofproteolytic and antiproteolytic activities that regulates matrix turnover. This article summarizes the evidence that supports this contention, discusses the role ofPAspecific cell surface binding sites, and also draws attention to a number of instances in which the presence ofPAs cannot be reconciled with an exclusive function in ECM degradation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
Vassalli, J. D., Baccino, D., & Belin, D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.1.86 · Cited by 712
Self-citationPloug, M., Rønne, E., Behrendt, N., Jensen, A. L., Blasi, F., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52382-6 · Cited by 574
Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.
HE, C. S., Wilhelm, S. M., Pentland, A. P., Marmer, B. L., Grant, G. A., Eisen, A. Z., & Goldberg, G. I. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2632 · Cited by 572
Pyke, C., Kristensen, P. K., Ralfkiaer, E. M., Grøndahl-Hansen, J., Eriksen, J., Blasi, F., & Danø, K. (1991) · PubMed · Cited by 471
Estreicher, A., Mühlhauser, J., Carpentier, J. L., Orci, L., & Vassalli, J. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.783 · Cited by 469
Self-citationPepper, M. S., Belin, D., Montesano, R., Orci, L., & Vassalli, J. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.743 · Cited by 453
Self-citationMiles, L. A., Dahlberg, C. M., Plescia, J., Felez, J., Kato, K., & Plow, E. F. (1991) · Biochemistry · doi:10.1021/bi00220a034 · Cited by 451
Plasminogen activator inhibitors: hormonally regulated serpins
Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A., & Stacey, S. N. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90164-4 · Cited by 398
Kobayashi, H., Schmitt, M., Goretzki, L., Chucholowski, N., Calvete, J., Kramer, M., Günzler, W. A., Jänicke, F., & Graeff, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67767-7 · Cited by 343
Cited by
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Transforming growth factor-beta in disease: the dark side of tissue repair.
Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,105
Physiological consequences of loss of plasminogen activator gene function in mice
Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D., & Mulligan, R. C. (1994) · Nature · doi:10.1038/368419a0 · Cited by 1,037
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
Cerebral Microvessel Responses to Focal Ischemia
del Zoppo, G. J., & Mabuchi, T. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000078322.96027.78 · Cited by 602
The Matrix Metalloproteinases and Their Inhibitors
Murphy, G., & Docherty, A. J. P. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/7.2.120 · Cited by 597
Impaired wound healing in mice with a disrupted plasminogen gene
Rømer, J., Bugge, T. H., Fyke, C., Lund, L. R., Flick, M. J., Degen, J. L., & Danø, K. (1996) · Nature Medicine · doi:10.1038/nm0396-287 · Cited by 561
Lund, L. R., Rømer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Danø, K., & Werb, Z. (1996) · Development · doi:10.1242/dev.122.1.181 · Cited by 546
Acidic pH enhances the invasive behavior of human melanoma cells
Mart�nez-Zaguil�n, R., Seftor, E. A., Seftor, R. E. B., Chu, Y.-W., Gillies, R. J., & Hendrix, M. J. C. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00121214 · Cited by 507
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Deng, G., Curriden, S. A., Wang, S., Rosenberg, S., & Loskutoff, D. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.6.1563 · Cited by 448
The cell biology of leukocyte-mediated proteolysis
Owen, C. A., & Campbell, E. J. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.2.137 · Cited by 439
Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.
Bugge, T. H., Flick, M. J., Daugherty, C. C., & Degen, J. L. (1995) · Genes & Development · doi:10.1101/gad.9.7.794 · Cited by 438
Cytokine regulation of metalloproteinase gene expression
Mauviel, A. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530404 · Cited by 432
Loss of Fibrinogen Rescues Mice from the Pleiotropic Effects of Plasminogen Deficiency
Bugge, T. H., Kombrinck, K. W., Flick, M. J., Daugherty, C. C., Danton, M. J. S., & Degen, J. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81390-2 · Cited by 424
Bergmann, S., Rohde, M., Chhatwal, G. S., & Hammerschmidt, S. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02448.x · Cited by 423
The astacin family of metalloendopeptidases
Bond, J. S., & Beynon, R. J. (1995) · Protein Science · doi:10.1002/pro.5560040701 · Cited by 408
Mechanisms of Venous Thrombosis and Resolution
Wakefield, T. W., Myers, D. D., & Henke, P. K. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.162289 · Cited by 393
Effects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice
Ploplis, V. A., Carmeliet, P., Vazirzadeh, S., Van Vlaenderen, I., Moons, L., Plow, E. F., & Collen, D. (1995) · Circulation · doi:10.1161/01.cir.92.9.2585 · Cited by 386
Sivasubramanian, N., Coker, M. L., Kurrelmeyer, K. M., MacLellan, W. R., DeMayo, F. J., Spinale, F. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/hc3401.093154 · Cited by 382
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury
Idell, S. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057846.21303.ab · Cited by 381
THE MAMMALIAN LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILY
Hussain, M. M., Strickland, D. K., & Bakillah, A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.141 · Cited by 377
ADAMTS: a novel family of extracellular matrix proteases
Tang, B. L. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00061-3 · Cited by 361
Eddy, A. A., Giachelli, C. M., McCulloch, W. T. T. A. O. L., & Liu, E. (1995) · Kidney International · doi:10.1038/ki.1995.218 · Cited by 359
Extracellular proteolysis in the adult murine brain.
Sappino, A. P., Madani, R., Huarte, J., Belin, D., Kiss, J. Z., Wohlwend, A., & Vassalli, J. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116637 · Cited by 356
Self-citationCarmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., & Mulligan, R. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116892 · Cited by 345
Coleman, J. L., Gebbia, J. A., Piesman, J., Degen, J. L., Bugge, T. H., & Benach, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80298-6 · Cited by 341
Sennoune, S. R., Bakunts, K., Martínez, G. M., Chua-Tuan, J. L., Kebir, Y., Attaya, M. N., & Martínez-Zaguilán, R. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00407.2003 · Cited by 333
Human trophoblast function during the implantation process
Staun-Ram, E., & Shalev, E. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-56 · Cited by 322
Essig, M., Nguyen, G., Prié, D., Escoubet, B., Sraer, J.-D., & Friedlander, G. (1998) · Circulation Research · doi:10.1161/01.res.83.7.683 · Cited by 316
Mutin, M., Canavy, I., Blann, A., Bory, M., Sampol, J., & Dignat-George, F. (1999) · Blood · doi:10.1182/blood.v93.9.2951 · Cited by 315
Caliezi, C., Wuillemin, W. A., Zeerleder, S., Redondo, M., Eisele, B., & Hack, C. E. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01437-6 · Cited by 312
Samad, F., Yamamoto, K., & Loskutoff, D. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118404 · Cited by 301
Hemostatic strategies for traumatic and surgical bleeding
Behrens, A. M., Sikorski, M. J., & Kofinas, P. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35052 · Cited by 300
The urokinase receptor is required for human monocyte chemotaxis in vitro.
Gyetko, M. R., Todd, R. F., Wilkinson, C. C., & Sitrin, R. G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117114 · Cited by 298
Amyloids — a functional coat for microorganisms
Gebbink, M. F. B. G., Claessen, D., Bouma, B., Dijkhuizen, L., & Wösten, H. A. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1127 · Cited by 288
Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease
Dellas, C., & Loskutoff, D. J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-01-0033 · Cited by 285
Madani, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3007 · Cited by 276
PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction
Oda, T., Jung, Y. O., Kim, H. S., Cai, X., López-Guisa, J. M., Ikeda, Y., & Eddy, A. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.030002587.x · Cited by 274
Complete Deficiency of Plasminogen-Activator Inhibitor Type 1 Due to a Frame-Shift Mutation
Fay, W. P., Shapiro, A. D., Shih, J. L., Schleef, R. R., & Ginsburg, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212103272406 · Cited by 271
Cao, J., Sato, H., Takino, T., & Seiki, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.801 · Cited by 270
Upregulation of urokinase receptor expression on migrating endothelial cells
Pepper, M., Sappino, A., Stöcklin, R., Montesano, R., Orci, L., & Vassalli, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.3.673 · Cited by 270
Self-citationMandriota, S. J., Seghezzi, G., Vassalli, J.-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P., & Pepper, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9709 · Cited by 267
Self-citationBleomycin-induced pulmonary fibrosis in fibrinogen-null mice
Hattori, N., Degen, J. L., Sisson, T. H., Liu, H., Moore, B. B., Pandrangi, R. G., Simon, R. H., & Drew, A. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10531 · Cited by 265
Manipulating Angiogenesis: From Basic Science to the Bedside
Pepper, M. S. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.605 · Cited by 261
Active cell death in hormone-dependent tissues
Tenniswood, M. P., Guenette, R. S., Lakins, J., Mooibroek, M., Wong, P., & Welsh, J. E. (1992) · Cancer and Metastasis Review · doi:10.1007/bf00048064 · Cited by 261
Owen, C. A., Hu, Z., Lopez-Otin, C., & Shapiro, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7791 · Cited by 257
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
Brown, N. J., Nakamura, S., Ma, L., Nakamura, I., Donnert, E., Freeman, M., Vaughan, D. E., & Fogo, A. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00277.x · Cited by 255
Feener, E. P., Northrup, J. M., Aiello, L. P., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117786 · Cited by 255
Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver
Bezerra, J. A., Bugge, T. H., Melin-Aldana, H., Sabla, G., Kombrinck, K. W., Witte, D. P., & Degen, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15143 · Cited by 137
Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes
Barrick, B., Campbell, E. J., & Owen, C. A. (1999) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1999.00410.x · Cited by 134
Takeuchi, M., Kosiewicz, M. M., Alard, P., & Streilein, J. W. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270709 · Cited by 119
Jolodar, A., Fischer, P., Bergmann, S., Büttner, D. W., Hammerschmidt, S., & Brattig, N. W. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(03)00083-6 · Cited by 115
Metabolic enzymes that bind RNA: yet another level of cellular regulatory network?
Cieśla, J. (2006) · Acta Biochimica Polonica · doi:10.18388/abp.2006_3360 · Cited by 106
González-Miguel, J., Morchón, R., Mellado, I., Carretón, E., Montoya-Alonso, J. A., & Simón, F. (2012) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2011.10.010 · Cited by 55
Shen, L. H., Xin, H., Li, Y., Zhang, R. L., Cui, Y., Zhang, L., Lu, M., Zhang, Z. G., & Chopp, M. (2011) · Stroke · doi:10.1161/strokeaha.110.593863 · Cited by 51
Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H., & Tomonaga, M. (1998) · Brain Tumor Pathology · doi:10.1007/bf02482097 · Cited by 25
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
Caraci, F., Iulita, M. F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., & Cuello, A. C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.004 · Cited by 18
Metadata
- Authors
- Vassalli, J. D., Sappino, A. P., & Belin, D.
- Venue
- Journal of Clinical Investigation
- Published
- 1991-10-01
- Volume
- 88
- Issue
- 4
- Pages
- 1067-1072
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2107908226
- Cited by
- 1,164
- References
- 37
- FWCI
- 22.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.